| Catalog Number |
140.954 |
| Medical Device Problem Code |
Failure to Osseointegrate (1863)
|
| Health Effect - Clinical Code |
Pain (1994)
|
| Date of Event |
07/17/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
The clinician reports the implant was inserted (b)(6) 2025 in ada 16.On (b)(6) 2026, non-osseointegration was verified.Patient presented with bone type iv.No product was returned to the manufacturer.At the event the patient experienced: pain.No further patient complications were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
The batch number could be verified.Our manufacturing q-system assures,
that production and process controls are in place to ensure that batches
confirm to the applicable specifications before they are distributed.?
the non-integration of an endosseous dental implant during the healing
phase is a known inherent risk of the treatment with dental implants.Most implant failures occur before occlusal loading (analainen et al.2009).Based on clinical studies about 1-3% of the implants fail within
the first year after implantation (ganeles et al.2008).Implants may have to be removed in case one or more of the implant
success criteria are not met.Implant success criteria according to buser et al.(1991) are:
1.Absence of persistent subjective complaints such as pain, foreign
body sensation and /or dysesthesia.2.Absence of a recurrent peri-implant infection with suppuration.3.Absence of implant mobility.4.Absence of a continuous radiolucency around the implant.The manufacturer's trend analysis confirms that the reported early
failure rate associated with its dental implants is below the expected
failure rate for this treatment as published in the scientific
literature.Non-fatal serious injury or device malfunction stored due to covid 19
pandemic in accordance with fda guidance "postmarketing adverse event
reporting for medical products and dietary supplements during a
pandemic" published may 2020.
|
| |
|
Search Alerts/Recalls
|